Hair cortisol and cortisone measurements for the diagnosis of overt and mild Cushing’s syndrome

in European Journal of Endocrinology
View More View Less
  • 1 Department of Nuclear Medicine, University Hospital of Bordeaux, Bordeaux, France
  • 2 Nutrition et Neurobiologie Intégrée, University of Bordeaux, Bordeaux, France
  • 3 Department of Endocrinology, Diabetes and Nutrition, CHU of Bordeaux and University of Bordeaux, France
  • 4 Department of Radiology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
  • 5 Department of Clinical‑Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy

Correspondence should be addressed to A Tabarin; Email: antoine.tabarin@chu-bordeaux.fr

*(J Brossaud and L Charret contributed equally to this work)

Restricted access

Objective

Hair cortisol (HF) and cortisone (HE) measurements reflect tissular exposure to cortisol over months and are increased in overt Cushing’s syndrome (CS). No data is available in mild CS. We compared the diagnostic performance of HF and HE between patients with overt or mild CS.

Design

Single centre retrospective study.

Methods

HF&HE were measured by LC-MS/MS in 48 consecutive adult females with Cushing’s disease (CD), ectopic ACTH syndrome, secreting adenomas and carcinomas, and adrenal incidentalomas. All had impaired dexamethasone suppression tests. Overt CS (n = 25) was diagnosed in front of specific symptoms, a mean UFC (>1.5 ULN) and increased midnight serum cortisol or salivary cortisol. Mild CS (n = 23) was diagnosed in patients lacking specific symptoms and displaying at least one additional biological abnormality including mildly increased UFC (≤1.5 ULN), increased midnight serum cortisol or salivary cortisol and suppressed plasma ACTH in patients with adrenal tumours. In this study, 84 healthy subjects and obese patients served as controls.

Results

HF and HE showed roughly similar performance in overt CS (92 and 100% sensitivity, 91 and 99% specificity, respectively). HF and HE were lower in mild CS but higher than in controls (P < 0.01). HE was correlated with midnight serum cortisol (P < 0.02) and volume of adrenal incidentalomas (P < 0.04) but not with UFC. HF and HE had 59% and 68% sensitivity, and 79 and 94% specificity, respectively, for the diagnosis of mild CS. Contrary to UFC, both HF and HE were in the range of overt CS in 11/23 patients with mild CS. Patients with mild CS and increased HE required more antihypertensive treatments and showed worser lipid profiles than patients with normal HE.

Conclusions

HF and HE measurement performed better in overt than in mild CS but is a useful adjunct to diagnose mild CS and to identify adrenocortical incidentalomas responsible for excessive cortisol exposure.

 

     European Society of Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 85 85 85
Full Text Views 15 15 15
PDF Downloads 13 13 13
  • 1

    Galm BP, Qiao N, Klibanski A, Biller BMK & Tritos NA Accuracy of laboratory tests for the diagnosis of Cushing syndrome. Journal of Clinical Endocrinology and Metabolism 2020 105 20812094. (https://doi.org/10.1210/clinem/dgaa105)

    • Search Google Scholar
    • Export Citation
  • 2

    Sandouk Z, Johnston P, Bunch D, Wang S, Bena J, Hamrahian A & Kennedy L Variability of late-night salivary cortisol in Cushing disease: a prospective study. Journal of Clinical Endocrinology and Metabolism 2018 103 983990. (https://doi.org/10.1210/jc.2017-02020)

    • Search Google Scholar
    • Export Citation
  • 3

    Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Sen K, Salgado LR, Colao A, Biller BMKPasireotide B2305 Study Group. High variability in baseline urinary free cortisol values in patients with Cushing’s disease. Clinical Endocrinology 2014 80 261269. (https://doi.org/10.1111/cen.12259)

    • Search Google Scholar
    • Export Citation
  • 4

    Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 15261540. (https://doi.org/10.1210/jc.2008-0125)

    • Search Google Scholar
    • Export Citation
  • 5

    Wester VL, Reincke M, Koper JW, Akker ELT, van den Manenschijn L, Berr CM, Fazel J, Rijke YB, de Feelders RA & van Rossum EFC Scalp hair cortisol for diagnosis of Cushing’s syndrome. European Journal of Endocrinology 2017 176 695703. (https://doi.org/10.1530/EJE-16-0873)

    • Search Google Scholar
    • Export Citation
  • 6

    Manenschijn L, Koper JW, van den Akker EL, de Heide LJ, Geerdink EA, de Jong FH, Feelders RA & van Rossum EF A novel tool in the diagnosis and follow-up of (cyclic) Cushing’s syndrome: measurement of long-term cortisol in scalp hair. Journal of Clinical Endocrinology and Metabolism 2012 97 E1836E1843. (https://doi.org/10.1210/jc.2012-1852)

    • Search Google Scholar
    • Export Citation
  • 7

    Savas M, Wester VL, Rijke YB de, Rubinstein G, Zopp S, Dorst K, Berg SAA van den, Beuschlein F, Feelders RA & Reincke M Hair glucocorticoids as a biomarker for endogenous Cushing’s syndrome: validation in two independent cohorts. Neuroendocrinology 2019 109 171178. (https://doi.org/10.1159/000498886)

    • Search Google Scholar
    • Export Citation
  • 8

    Thomson S, Koren G, Fraser LA, Rieder M, Friedman TC & Van Uum SHM Hair analysis provides a historical record of cortisol levels in Cushing’s syndrome. Experimental and Clinical Endocrinology and Diabetes 2010 118 133138. (https://doi.org/10.1055/s-0029-1220771)

    • Search Google Scholar
    • Export Citation
  • 9

    Smith RE, Maguire JA, Stein-Oakley AN, Sasano H, Takahashi K, Fukushima K & Krozowski ZS Localization of 11 beta-hydroxysteroid dehydrogenase type II in human epithelial tissues. Journal of Clinical Endocrinology and Metabolism 1996 81 32443248. (https://doi.org/10.1210/jcem.81.9.8784076)

    • Search Google Scholar
    • Export Citation
  • 10

    Chiodini I Clinical review: diagnosis and treatment of subclinical hypercortisolism. Journal of Clinical Endocrinology and Metabolism 2011 96 12231236. (https://doi.org/10.1210/jc.2010-2722)

    • Search Google Scholar
    • Export Citation
  • 11

    Kidambi S, Raff H & Findling JW Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. European Journal of Endocrinology 2007 157 725731. (https://doi.org/10.1530/EJE-07-0424)

    • Search Google Scholar
    • Export Citation
  • 12

    Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S & Dekkers OM Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. European Journal of Endocrinology 2016 175 G1G34. (https://doi.org/10.1530/EJE-16-0467)

    • Search Google Scholar
    • Export Citation
  • 13

    Cambos S & Tabarin A Management of adrenal incidentalomas: working through uncertainty. Best Practice and Research: Clinical Endocrinology and Metabolism 2020 34 101427. (https://doi.org/10.1016/j.beem.2020.101427)

    • Search Google Scholar
    • Export Citation
  • 14

    Nunes ML, Vattaut S, Corcuff JB, Rault A, Loiseau H, Gatta B, Valli N, Letenneur L & Tabarin A Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalized and ambulatory patients. Journal of Clinical Endocrinology and Metabolism 2009 94 456462. (https://doi.org/10.1210/jc.2008-1542)

    • Search Google Scholar
    • Export Citation
  • 15

    Giorgi RB, Correa MV, Costa-Barbosa FA & Kater CE Cyclic subclinical hypercortisolism: a previously unidentified hypersecretory form of adrenal incidentalomas. Journal of the Endocrine Society 2019 3 678686. (https://doi.org/10.1210/js.2018-00385)

    • Search Google Scholar
    • Export Citation
  • 16

    Terzolo M, Stigliano A, Chiodini I, Loli P, Furlani L, Arnaldi G, Reimondo G, Pia A, Toscano V & Zini M AME position statement on adrenal incidentaloma. European Journal of Endocrinology 2011 164 851870. (https://doi.org/10.1530/EJE-10-1147)

    • Search Google Scholar
    • Export Citation
  • 17

    Stewart PM Is subclinical Cushing’s syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined. Journal of Clinical Endocrinology and Metabolism 2010 95 26182620. (https://doi.org/10.1210/jc.2010-0633)

    • Search Google Scholar
    • Export Citation
  • 18

    Danet-Lamasou M, Asselineau J, Perez P, Vivot A, Nunes ML, Loiseau H, San-Galli F, Cherifi-Gatta B, Corcuff JB & Tabarin A Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing’s disease following pituitary surgery. Clinical Endocrinology 2015 82 260266. (https://doi.org/10.1111/cen.12534)

    • Search Google Scholar
    • Export Citation
  • 19

    Carroll TB, Javorsky BR & Findling JW Postsurgical recurrent Cushing disease: clinical benefit of early intervention in patients WITH normal urinary free cortisol. Endocrine Practice 2016 22 12161223. (https://doi.org/10.4158/EP161380.OR)

    • Search Google Scholar
    • Export Citation
  • 20

    Tabarin A & Perez P Pros and cons of screening for occult Cushing syndrome. Nature Reviews. Endocrinology 2011 7 445455. (https://doi.org/10.1038/nrendo.2011.51)

    • Search Google Scholar
    • Export Citation
  • 21

    Elias PCL, Martinez EZ, Barone BFC, Mermejo LM, Castro M & Moreira AC Late-night salivary cortisol has a better performance than urinary free cortisol in the diagnosis of Cushing’s syndrome. Journal of Clinical Endocrinology and Metabolism 2014 99 20452051. (https://doi.org/10.1210/jc.2013-4262)

    • Search Google Scholar
    • Export Citation
  • 22

    Maxwell M, Heaney D, Howie JG & Noble S General practice fundholding: observations on prescribing patterns and costs using the defined daily dose method. BMJ 1993 307 11901194. (https://doi.org/10.1136/bmj.307.6913.1190)

    • Search Google Scholar
    • Export Citation
  • 23

    Raff H & Phillips JM Bedtime salivary cortisol and cortisone by LC-MS/MS in healthy adult subjects: evaluation of sampling time. Journal of the Endocrine Society 2019 3 16311640. (https://doi.org/10.1210/js.2019-00186)

    • Search Google Scholar
    • Export Citation
  • 24

    Stewart PM, Walker BR, Holder G, O’Halloran D & Shackleton CH 11 Beta-hydroxysteroid dehydrogenase activity in Cushing’s syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. Journal of Clinical Endocrinology and Metabolism 1995 80 36 173620. (https://doi.org/10.1210/jcem.80.12.8530609)

    • Search Google Scholar
    • Export Citation
  • 25

    Noppe G, Rijke YB de, Dorst K, Akker ELT van den & Rossum EFC LC-MS/MS-based method for long-term steroid profiling in human scalp hair. Clinical Endocrinology 2015 83 162166. (https://doi.org/10.1111/cen.12781)

    • Search Google Scholar
    • Export Citation
  • 26

    Gaudl A, Kratzsch J, Bae YJ, Kiess W, Thiery J & Ceglarek U Liquid chromatography quadrupole linear ion trap mass spectrometry for quantitative steroid hormone analysis in plasma, urine, saliva and hair. Journal of Chromatography A 2016 1464 6471. (https://doi.org/10.1016/j.chroma.2016.07.087)

    • Search Google Scholar
    • Export Citation
  • 27

    Hamel AF, Meyer JS, Henchey E, Dettmer AM, Suomi SJ & Novak MA Effects of shampoo and water washing on hair cortisol concentrations. Clinica Chimica Acta: International Journal of Clinical Chemistry 2011 412 382385. (https://doi.org/10.1016/j.cca.2010.10.019)

    • Search Google Scholar
    • Export Citation
  • 28

    Staufenbiel SM, Penninx BWJH, Rijke YB de, Akker ELT van den & Rossum EFC van Determinants of hair cortisol and hair cortisone concentrations in adults. Psychoneuroendocrinology 2015 60 182194. (https://doi.org/10.1016/j.psyneuen.2015.06.011)

    • Search Google Scholar
    • Export Citation
  • 29

    Papanicolaou DA, Yanovski JA, Cutler GB, Chrousos GP & Nieman LK A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states. Journal of Clinical Endocrinology and Metabolism 1998 83 11631167. (https://doi.org/10.1210/jcem.83.4.4733)

    • Search Google Scholar
    • Export Citation
  • 30

    Bou Khalil R, Baudry C, Guignat L, Carrasco C, Guibourdenche J, Gaillard S, Bertagna X & Bertherat J Sequential hormonal changes in 21 patients with recurrent Cushing’s disease after successful pituitary surgery. European Journal of Endocrinology 2011 165 729737. (https://doi.org/10.1530/EJE-11-0424)

    • Search Google Scholar
    • Export Citation
  • 31

    Masserini B, Morelli V, Bergamaschi S, Ermetici F, Eller-Vainicher C, Barbieri AM, Maffini MA, Scillitani A, Ambrosi B & Beck-Peccoz P et al. The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. European Journal of Endocrinology 2009 160 8792. (https://doi.org/10.1530/EJE-08-0485)

    • Search Google Scholar
    • Export Citation
  • 32

    Ueland , Methlie P, Kellmann R, Bjørgaas M, Åsvold BO, Thorstensen K, Kelp O, Thordarson HB, Mellgren G & Løvås K et al. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test. European Journal of Endocrinology 2017 176 705713. (https://doi.org/10.1530/EJE-17-0078)

    • Search Google Scholar
    • Export Citation
  • 33

    Ceccato F, Barbot M, Albiger N, Antonelli G, Zilio M, Todeschini M, Regazzo D, Plebani M, Lacognata C & Iacobone M et al. Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma. Endocrine 2018 59 510519. (https://doi.org/10.1007/s12020-017-1421-3)

    • Search Google Scholar
    • Export Citation
  • 34

    Stalder T, Kirschbaum C, Alexander N, Bornstein SR, Gao W, Miller R, Stark S, Bosch JA & Fischer JE Cortisol in hair and the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism 2013 98 25732580. (https://doi.org/10.1210/jc.2013-1056)

    • Search Google Scholar
    • Export Citation
  • 35

    Bancos I, Alahdab F, Crowley RK, Chortis V, Delivanis DA, Erickson D, Natt N, Terzolo M, Arlt W & Young WF Therapy of endocrine disease: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing’s syndrome: a systematic review and meta-analysis. European Journal of Endocrinology 2016 175 R283R295. (https://doi.org/10.1530/EJE-16-0465)

    • Search Google Scholar
    • Export Citation
  • 36

    Eller-Vainicher C, Morelli V, Salcuni AS, Battista C, Torlontano M, Coletti F, Iorio L, Cairoli E, Beck-Peccoz P & Arosio M et al. Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma. European Journal of Endocrinology 2010 163 925935. (https://doi.org/10.1530/EJE-10-0602)

    • Search Google Scholar
    • Export Citation
  • 37

    Abell JG, Stalder T, Ferrie JE, Shipley MJ, Kirschbaum C, Kivimäki M & Kumari M Assessing cortisol from hair samples in a large observational cohort: the Whitehall II study. Psychoneuroendocrinology 2016 73 148156. (https://doi.org/10.1016/j.psyneuen.2016.07.214)

    • Search Google Scholar
    • Export Citation
  • 38

    Wester VL & Rossum EFC van Clinical applications of cortisol measurements in hair. European Journal of Endocrinology 2015 173 M1M10. (https://doi.org/10.1530/EJE-15-0313)

    • Search Google Scholar
    • Export Citation
  • 39

    Kannankeril J, Carroll T, Findling JW, Javorsky B, Gunsolus IL, Phillips J & Raff H Prospective evaluation of late-night salivary cortisol and cortisone by EIA and LC-MS/MS in suspected Cushing syndrome. Journal of the Endocrine Society 2020 4 bvaa107. (https://doi.org/10.1210/jendso/bvaa107)

    • Search Google Scholar
    • Export Citation
  • 40

    Findling JW & Raff H Diagnosis of endocrine disease: differentiation of pathologic/neoplastic hypercortisolism (Cushing’s syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing’s syndrome). European Journal of Endocrinology 2017 176 R205R216. (https://doi.org/10.1530/EJE-16-0946)

    • Search Google Scholar
    • Export Citation
  • 41

    Wester VL, Staufenbiel SM, Veldhorst MAB, Visser JA, Manenschijn L, Koper JW, Klessens-Godfroy FJM, Akker ELT van den & Rossum EFC van Long-term cortisol levels measured in scalp hair of obese patients. Obesity 2014 22 19561958. (https://doi.org/10.1002/oby.20795)

    • Search Google Scholar
    • Export Citation
  • 42

    Chan J, Sauvé B, Tokmakejian S, Koren G & Van Uum S Measurement of cortisol and testosterone in hair of obese and non-obese human subjects. Experimental and Clinical Endocrinology and Diabetes 2014 122 356362. (https://doi.org/10.1055/s-0034-1374609)

    • Search Google Scholar
    • Export Citation
  • 43

    Bäcklund N, Brattsand G, Israelsson M, Ragnarsson O, Burman P, Engström BE, Høybye C, Berinder K, Wahlberg J & Olsson T et al. Reference intervals of salivary cortisol and cortisone and their diagnostic accuracy in Cushing’s syndrome. European Journal of Endocrinology 2020 182 569582. (https://doi.org/10.1530/EJE-19-0872)

    • Search Google Scholar
    • Export Citation
  • 44

    Di Dalmazi G, Fanelli F, Zavatta G, Ricci Bitti S, Mezzullo M, Repaci A, Pelusi C, Gambineri A, Altieri P & Mosconi C et al. The steroid profile of adrenal incidentalomas: subtyping subjects with high cardiovascular risk. Journal of Clinical Endocrinology and Metabolism 2019 104 55195528. (https://doi.org/10.1210/jc.2019-00365)

    • Search Google Scholar
    • Export Citation